Evidence map›Paper›PMID 24386442›Full record

Trial reportPloS one2013

Novel and predominant pathogen responsible for the enterovirus-associated encephalitis in eastern China.

Lei Zhang, Jie Yan, David M Ojcius, Huakun Lv, Ziping Miao, Yin Chen, Yanjun Zhang, Jvying Yan

Abstract readClinical Trial
In one paragraph

Trial report in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lei ZhangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, P.R.China.
Jie YanDivision of Basic Medical Microbiology, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
David M OjciusHealth Sciences Research Institute and School of Natural Sciences, University of California, Merced, Merced, California, United States of America.
Huakun LvZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, P.R.China.
Ziping MiaoZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, P.R.China.
Yin ChenZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, P.R.China.
Yanjun ZhangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, P.R.China.
Jvying YanZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, P.R.China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enteroviruses (EV) have been increasingly identified as the causative agent for unknown etiological encephalitis in many parts of the world, but the long period surveillance for enterovirus-associated encephalitis (EAE) was not reported in China. From 2002-2012 in Zhejiang, Coxsackieviruses A9, B1, B2, B3, B4, B5; and echoviruses 3, 4, 6, 9, 14, 25, 30 were detected from the unknown etiological encephalitis cases, with coxsackievirus B4 been identified here for the first time. From 2002-2004 and 2010-2012, echovirus 30 was found to be the periodically predominant serotype for in the EAE. The molecular typing results showed that all the EV isolates from this study belonged to the human EV B (HEV B) family and were distributed in three clusters.

Indexed as

Encephalitis, ViralEnterovirusAdolescentChildChild, PreschoolChinaFemaleHumansInfantMaleRetrospective Studies

Identifiers

PMID24386442
PMCPMC3875553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.